GENERA ISTRAZIVANJA D O O has a total of 28 patent applications. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are IMMUNAID PTY LTD, BIOINCEPT LLC and MEDINNOVA GES MED INNOVATIONEN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | Australia | 6 | |
#3 | United States | 6 | |
#4 | Japan | 4 | |
#5 | Hong Kong | 2 | |
#6 | Canada | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Peptides | |
#5 | Microorganisms | |
#6 | Syringes | |
#7 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Vukicevic Slobodan | 24 |
#2 | Grgurevic Lovorka | 20 |
#3 | Macek Boris | 11 |
#4 | Slobodan Vukicevic | 4 |
#5 | Lovorka Grgurevic | 4 |
#6 | Dumic-Cule Ivo | 4 |
#7 | Boris Macek | 4 |
#8 | Oppermann Hermann | 2 |
#9 | Jelic Mislav | 2 |
#10 | Simic Petra | 2 |
Publication | Filing date | Title |
---|---|---|
EP2841100A1 | Methods and compositions for treating and diagnosing acute myocardial infarction | |
AU2013202145A1 | Blood biomarkers for bone fracture and cartilage injury | |
AU2012200193A1 | BMP-1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders | |
EP2171450A2 | Adamts4 as a blood biomarker and therapeutic target for chronic renal failure | |
AU2008246125A1 | Blood biomarkers for bone fracture and cartilage injury | |
AU2006275444A1 | Methods and compositions for regenerating articular cartilage |